AIG
IONS icon

American International Group’s Ionis Pharmaceuticals IONS Stock Holding History

American International Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,208
Closed -$95.7K – 1318
2024
Q1 		$95.7K Sell
2,208
-29
-1% -$1.38K ﹤0.01% 2545
2023
Q4 		$113K Sell
2,237
-61
-3% -$2.92K ﹤0.01% 2491
2023
Q3 		$104K Sell
2,298
-157
-6% -$6.48K ﹤0.01% 2490
2023
Q2 		$101K Buy
2,455
+409
+20% +$15.7K ﹤0.01% 2570
2023
Q1 		$73.1K Sell
2,046
-60
-3% -$2.25K ﹤0.01% 2591
2022
Q4 		$79.5K Sell
2,106
-47
-2% -$1.98K ﹤0.01% 2603
2022
Q3 		$95K Buy
2,153
+6
+0.3% +$253 ﹤0.01% 2583
2022
Q2 		$79K Sell
2,147
-421
-16% -$15.9K ﹤0.01% 2712
2022
Q1 		$95K Sell
2,568
-3
-0.1% -$98 ﹤0.01% 2613
2021
Q4 		$78K Sell
2,571
-89
-3% -$2.8K ﹤0.01% 2822
2021
Q3 		$89K Sell
2,660
-208
-7% -$7.84K ﹤0.01% 2845
2021
Q2 		$114 Buy
2,868
+633
+28% +$24.8K ﹤0.01% 2832
2021
Q1 		$100 Sell
2,235
-239
-10% -$13.3K ﹤0.01% 2718
2020
Q4 		$140 Sell
2,474
-72
-3% -$3.59K ﹤0.01% 2474
2020
Q3 		$121K Sell
2,546
-79
-3% -$4.39K ﹤0.01% 2425
2020
Q2 		$155K Sell
2,625
-285
-10% -$15.9K ﹤0.01% 2274
2020
Q1 		$138K Sell
2,910
-92
-3% -$5.13K ﹤0.01% 2118
2019
Q4 		$181K Sell
3,002
-127
-4% -$7.57K ﹤0.01% 2285
2019
Q3 		$187K Hold
3,129
– – ﹤0.01% 2205
2019
Q2 		$201K Buy
3,129
+213
+7% +$15.1K ﹤0.01% 2228
2019
Q1 		$237K Sell
2,916
-103
-3% -$6.64K ﹤0.01% 2120
2018
Q4 		$163K Hold
3,019
– – ﹤0.01% 2298
2018
Q3 		$156K Hold
3,019
– – ﹤0.01% 2571
2018
Q2 		$126K Buy
3,019
+202
+7% +$8.95K ﹤0.01% 2655
2018
Q1 		$124K Sell
2,817
-108
-4% -$5.49K ﹤0.01% 2542
2017
Q4 		$147K Buy
+2,925
New +$160K ﹤0.01% 2510
2017
Q3 		– Sell
-2,994
Closed -$152K – 2923
2017
Q2 		$152K Buy
2,994
+253
+9% +$11.8K ﹤0.01% 2447
2017
Q1 		$110K Sell
2,741
-104
-4% -$4.67K ﹤0.01% 2539
2016
Q4 		$136K Hold
2,845
– – ﹤0.01% 2416
2016
Q3 		$104K Sell
2,845
-123
-4% -$3.85K ﹤0.01% 2571
2016
Q2 		$69.1K Sell
2,968
-6,750
-69% -$218K ﹤0.01% 2836
2016
Q1 		$395K Sell
9,718
-1,283
-12% -$52.1K ﹤0.01% 2190
2015
Q4 		$681K Buy
11,001
+141
+1% +$7.61K ﹤0.01% 1778
2015
Q3 		$439K Sell
10,860
-1,736
-14% -$89.9K ﹤0.01% 2128
2015
Q2 		$725K Sell
12,596
-73,804
-85% -$4.69M ﹤0.01% 1851
2015
Q1 		$5.5M Buy
86,400
+2,647
+3% +$180K 0.02% 734
2014
Q4 		$5.17M Sell
83,753
-882
-1% -$43.5K 0.02% 731
2014
Q3 		$3.29M Buy
84,635
+863
+1% +$30.6K 0.01% 933
2014
Q2 		$2.89M Buy
83,772
+1,386
+2% +$43.6K 0.01% 974
2014
Q1 		$3.56M Buy
82,386
+4,188
+5% +$203K 0.02% 857
2013
Q4 		$3.12M Buy
78,198
+1,761
+2% +$62.7K 0.02% 902
2013
Q3 		$2.87M Sell
76,437
-2,160
-3% -$64.5K 0.02% 905
2013
Q2 		$2.11M Buy
+78,597
New +$1.67M 0.01% 1030

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

American International Group's IONS Position: Q2 2024 in Review

American International Group sold out of Ionis Pharmaceuticals (IONS) in Q2 2024, closing a stake of 2,208 shares — an estimated $95.7K sold.

American International Group first reported a position in IONS in Q2 2013 and held it in 43 quarters. The position peaked at $5.5M in Q1 2015. 356 funds tracked by Wall St. Rank hold IONS as of Q2 2024.

  • American International Group reported no remaining Ionis Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 2,208 Ionis Pharmaceuticals shares in Q2 2024, an estimated $95.7K.
  • American International Group first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 43 quarters.
  • American International Group's Ionis Pharmaceuticals position peaked at $5.5M in Q1 2015.
  • 356 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.